ArticleJournal for immunotherapy of cancer2026

Targeting RRBP1 reverses immune evasion and enhances immunotherapy efficacy via the CXCL10-CXCR3 axis in bladder cancer.

Chengquan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.